Review prescribing as a separate service commitment
New Jersey's July 2026 law changes specific Schedule II provisions. It should be assessed directly for the proposed practice rather than summarized as universal online prescribing permission. Current New Jersey statutory text
If the business offers medicine management beyond record review, define that scope before launch. Identify the clinician, evaluation method, required follow-up, and circumstances needing physical care. Do not bundle a guaranteed prescription with a consultation or vaccine-navigation purchase.
For controlled medications, the DEA and HHS fourth temporary extension of telemedicine prescribing flexibilities runs through December 31, 2026, subject to its conditions. It does not guarantee a prescription or replace state requirements, and any reliance on it beyond that date needs a fresh review. State rules and professional duties still matter. DEA and HHS temporary extension
Ask the clinical lead to review a case where a patient requests a medicine unrelated to the stated service. Staff should explain the scope without making clinical promises. Create a review date for time-limited rules. A workflow that is valid on one date should not continue into a later regulatory period without checking its basis.